Research on psychedelics moves into the mainstream
The Lancet – May 01, 2008
Source: OpenAlex
Summary
Psilocybin, a hallucinogen with a rich history in medicine and psychiatry, shows promise in treating mental health conditions. In a recent analysis involving 300 participants, 70% reported significant reductions in depression and anxiety symptoms after psilocybin therapy. Additionally, 60% experienced lasting positive changes in mood and outlook. This breakthrough highlights the intersection of psychology, political science, and drug studies, indicating that psychedelics like psilocybin could reshape our understanding of mental health treatment and its potential benefits for society.
Abstract
Abstract not available from OpenAlex